2024 HCPCS Code J7204
Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
TAGS: factor antihemophilic
Short Description | Inj recombin esperoct per iu |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | July 01, 2020 |
HCPCS Code Added Date | July 01, 2020 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J0490 - Belimumab injection
- J0491 - Inj anifrolumab-fnia 1mg
- J0500 - Dicyclomine injection
- J0515 - Inj benztropine mesylate
- J0517 - Inj., benralizumab, 1 mg
- J0520 - Bethanechol chloride inject
- J0558 - Peng benzathine/procaine inj
- J0561 - Penicillin g benzathine inj
- J0565 - Inj, bezlotoxumab, 10 mg
- J0567 - Inj., cerliponase alfa 1 mg
- J0570 - Buprenorphine implant 74.2mg
- J0571 - Buprenorphine oral 1mg
- J0572 - Bupren/nal up to 3mg bupreno
- J0573 - Bupren/nal 3.1 to 6mg bupren
- J0574 - Bupren/nal 6.1 to 10mg bupre
- J0575 - Bupren/nal over 10mg bupreno
- J0576 - Inj buprenorph (brixadi) 1mg
- J0577 - Inj, brixadi, 7 days or less
- J0578 - Inj brixadi, more than 7 day
- J0583 - Bivalirudin